Posted Apr. 30, 2012 at 3:10 p.m.

Premium Lock Pozen runs into a headache with FDA over safer aspirin

Published: 2012-04-30 15:10:37
Updated: 2012-04-30 15:10:37

Pozen's headaches

During a recent meeting with the FDA to discuss its submission, the agency suggested the Chapel Hill-based company also seek approval for the drug at a lower dose...

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll